NASDAQ:BCTX | Profit Breakdown | BriaCell Therapeutics Corp.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-07-31 to 2026-04-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-04-30-$7.62M-$7.16M
2026-01-31-$7.53M-$7.22M
2025-10-31-$8.32M-$8.2M
2025-07-31-$8.55M-$8.09M
2025-04-30-$6.33M-$6.13M
2025-01-31-$7.17M-$6.29M
2024-10-31-$5.15M-$5.8M
2024-07-31-$5.77M-$1.21M
2024-04-30-$9.23M$1.72M
2024-01-31-$9.83M-$11.29M
2023-10-31-$8.5M$6M
2023-07-31-$7.71M-$2.42M
2023-04-30-$5.68M-$4.9M
2023-01-31-$4.49M-$11.88M
2022-10-31-$5.4M-$1.11M
2022-07-31-$5.23M-$450,352.00
2022-04-30-$4.12M-$10.02M
2022-01-31-$3.65M$11.16M
2021-10-31-$2.28M-$27.53M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-07-31-$27.2M$26.56M-$26.31M
2024-07-31-$33.33M$4.93M-$4.79M
2023-07-31-$23.27M$20.3M-$20.3M
2022-07-31-$15.29M-$26.84M-$26.84M
2021-07-31-$6.98M-$13.82M-$13.82M